Access to treatment

Access to treatment for people with rare and genetic conditions is a really important issue for many of our members. Much of our work in this area is in the form of consultation responses, research and briefings to the National Institute for Health and Care Excellence (NICE), NHS England, the European Medicines Agency, the Scottish Medical Council and Welsh Health Specialised Services Committee as well as briefings to Parliament and the devolved administrations.